Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Vivos Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 4.69M | 4.48M | −216.8K (−4.6%) |
| Value | $2.39M | $860.6K | −$1.53M (−64.0%) |
New holders (6)
Institutions that held Vivos Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 87,697 | $16.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 53,334 | $10.2K | 0.00% |
| HighTower Advisors, LLC | 18,653 | $4.00K | 0.00% |
| UBS Group AG | 9,257 | $1.78K | 0.00% |
| Qube Research & Technologies Ltd | 200 | $38 | 0.00% |
| JPMorgan Chase & Co | 26 | $5 | 0.00% |
Sold out (9)
Institutions that held Vivos Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Godsey & Gibb Associates | 92,999 | $47.4K |
| Two Sigma Investments, LP | 63,301 | $32.3K |
| Virtu Financial LLC | 50,854 | $26.0K |
| Renaissance Technologies LLC | 33,551 | $17.0K |
| Tower Research Capital LLC (TRC) | 24,573 | $12.5K |
| Two Sigma Securities, LLC | 12,387 | $6.32K |
| Advisor Group Holdings, Inc. | 1,000 | $510 |
| The PNC Financial Services Group, Inc. | 500 | $255 |
| Capital Advisors, Ltd. LLC | 185 | $0 |